ArticleWorld journal of surgical oncology2025

Comparative efficacy and safety of lenvatinib, sintilimab combined interventional therapy vs bevacizumab, sintilimab combined interventional therapy in intermediate and advanced hepatocellular carcinoma: a multicenter retrospective study.

Yi-Xin Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.